Skip to main content
OpenTrials
Completed

NCT Number: NCT00826462

Treatment Study of Steroid Injection and Physical Therapy for Acute Lateral Epicondylitis

The purpose of this study is to compare the clinical effect of physiotherapy alone or combined with corticosteroid injection in the initial treatment of lateral epicondylitis in a primary care setting.

To find the short and long term effect of physiotherapy with Mill's manipulation, deep friction massage and exercise therapy.

To ascertain wether the outcome is influenced by corticosteroid injection, which has been shown to be of benefit alone in the short term?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tennis Elbow Arm Injuries Elbow Injuries Elbow Tendinopathy Epicondylitis, Lateral Humeral Muscular Diseases Musculoskeletal Diseases Tendinopathy Tendon Injuries Wounds and Injuries

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Grålum legesenter

Sarpsborg, 1712, Norway

About this study

Much has been written about lateral epicondylitis/tennis elbow reflecting the existence of many treatments for the condition. However, there is no consensus as to which treatment gives the best results.

Based on the latest meta-studies and reviews from the Cochrane Library, one may conclude that there is evidence of a short-term effect of topical or per oral NSAIDs. The same is true for manipulation and exercise. Corticosteroid injection has also been shown to have short-term effect, but not beyond 6 weeks. Ultrasound has a possible short-term effect based on one meta-analysis. Extra corporeal shock wave therapy does not seem to be effective. The treatment with acupuncture, orthosis, surgery or long-term NSAIDs has no support in the literature, and it is impossible to draw any conclusions about the effects or absence thereof. In fact, there is scant support for any long-term treatment in the literature.

We have found two studies to be of special interest (see citations below). Both have been done in a primary care setting with one-year follow up. One study compares corticosteroid injection with physical therapy (ultrasound, manipulation and exercise) and a wait-and-see group. The other compares corticosteroid injection with naproxen orally and placebo-medication. Both conclude that corticosteroid injection is a safe and effective treatment as pain-relief during the first 6 weeks, and that the effect of this treatment is better than physical therapy, wait-and-see and naproxen orally within the same time-frame. Physical therapy in one study gives some, but not statistically significantly better long-term (one year) effect than wait-and-see treatment.

There seems to be some indication that corticosteroid injection is a good alternative for the first 6 weeks. We find there is a good reason to investigate the long-term effects of physical therapy. At the same time, it would be interesting to see whether the good initial response from corticosteroid injection may be extended if combined with physiotherapy.

This randomised, placebo-controlled study will be conducted in general practice in the town of Sarpsborg, Ostfold County, Norway including patient aged 18-70 years with pain of recent onset from the lateral part of the elbow. After a treatment-period of 6 weeks, the patient is followed for a total of 12 months.

Patients are recruited by interested general practitioners in the city of Sarpsborg and surroundings and remitted to two study-physicians who make the initial evaluation of inclusion- and exclusion criteria, as well as treatment, follow-up and outcome assessments during the whole study-period. The patients are treated by one of the two study-physicians in the 6-weeks treatment-period. From the 6. week, the patient sees the other physician, who is unaware of the allocated intervention, for further registration and assessment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-70 years
  • Pain from the lateral part of the elbow
  • The pain increases on resisted dorsiflexion of the wrist with the elbow extended and the fingers flexed or the pain increases on resisted radial deviation of the wrist or the pain increases on resisted extension of the 3. finger

Exclusion criteria

  • Duration of complaints less than 2 weeks or more than 3 months
  • The tenderness is located within the muscle body itself in the proximal part of the short radial extensors muscle of the wrist (Cyriax type IV)9.
  • Treatment within the last 12 months for the same condition with corticosteroid injection or physiotherapy
  • Bilateral complaints
  • Previous surgical treatment for lateral epicondylitis
  • Deformities of the elbow (congenital or acquired)
  • Cervical radiculopathy or referred pain from neck or shoulder
  • Previous fractures or tendon ruptures in the elbow
  • Systemic musculoskeletal disease
  • Previous allergic reactions to corticosteroids or lidocaine
  • Contraindications to corticosteroids or NSAIDs:
  • On-going or previous gastro-intestinal bleeding
  • previous ulcer or dyspepsia, severe asthma
  • on-going systemic infection
  • local skin-infection
  • recently vaccinated with live virus
  • coagulopathies
  • systemic lupus erythematodes
  • severe liver- or kidney-disease
  • heart failure
  • diabetes
  • use of warfarin or NSAIDS
  • Pregnancy or breast-feeding
  • Fertile females not on effective birth control
  • Psycho-social or other reasons for not being able to participate throughout the study.

Treatment and study plan

Triamcinolone

Drug

Injection with triamcinolone 10 mg at start and at 3 weeks

Other names: Kenacort - T (triamcinolone), Xylocaine (lidocaine)

Placebo

Drug

Injection with sodium chloride at start and at 3 weeks

Other names: Sodium chloride

Lidocaine

Drug

10 mg of lidocaine at start and at 3 weeks

Other names: Xylocaine

Physiotherapy

Other

12 treatments with deep friction massage, Mill's manipulation, soft tissue treatment and home exercises

Other names: Physical therapy

Naproxen

Drug

Naproxen 500 mg bid for 14 days

Other names: Naprosyn entero

Primary outcomes

  1. Treatment Success - Event Rates in Each Group

    Time frame: 6 - 52 weeks

    Unadjusted event rates of treatment success, defined as participants rating themselves 'much improved' or 'completely recovered' on a six point scale. Percentage with 99% confidence interval.

Secondary outcomes

  1. Pain as Recorded by the Study Doctors on a Visual Analog Scale (VAS Scale)

    Time frame: 6 weeks

    Pain in elbow as recorded by the study doctors on a 100 mm VAS-scale (Visual Analog Scale). The scale runs from 0 mm (no pain) to 100 mm (maximum pain), higher scores means worse outcome.

  2. Pain as Recorded by the Study Doctors on a 100 mm VAS-scale (Visual Analog Scale).

    Time frame: 12 weeks

    Pain in elbow as recorded by the study doctors on a 100 mm VAS-scale (Visual Analog Scale). The scale runs from 0 mm (no pain) to 100 mm (maximum pain), higher scores means worse outcome.

  3. Pain as Recorded by the Study Doctors on a 100 mm VAS-scale (Visual Analog Scale).

    Time frame: 26 weeks

    Pain in elbow as recorded by the study doctors on a 100 mm VAS-scale (Visual Analog Scale). The scale runs from 0 mm (no pain) to 100 mm (maximum pain), higher scores means worse outcome.

  4. Pain as Recorded by the Study Doctors on a 100 mm VAS-scale

    Time frame: 52 weeks

    Pain in elbow as recorded by the study doctors on a 100 mm VAS-scale (Visual Analog Scale). The scale runs from 0 mm (no pain) to 100 mm (maximum pain), higher scores means worse outcome.

  5. Pain-free Grip Strength Ratio

    Time frame: 6 weeks

    Pain free grip strength registered with hand held dynamometer . Mean of three measurements as ratio of affected to unaffected side.Strength registered in kg. A ratio closer to zero signifies that pain occurs at the application of a small force signifying a more severe condition. A ratio approaching 1 signifies a milder complaint.

  6. Pain-free Grip Strength Ratio

    Time frame: 12 weeks

    Pain free grip strength registered with hand held dynamometer 30 31. Mean of three measurements as ratio of affected to unaffected side. Strength registered in kg. A ratio closer to zero signifies that pain occurs at the application of a small force signifying a more severe condition. A ratio approaching 1 signifies a milder complaint.

  7. Pain-free Grip Strength Ratio

    Time frame: 26 weeks

    Pain free grip strength registered with hand held dynamometer 30 31. Mean of three measurements as ratio of affected to unaffected side.Strength registered in kg. A ratio closer to zero signifies that pain occurs at the application of a small force signifying a more severe condition. A ratio approaching 1 signifies a milder complaint.

  8. Pain-free Grip Strength Ratio

    Time frame: 52 weeks

    Pain free grip strength registered with hand held dynamometer 30 31. Mean of three measurements as ratio of affected to unaffected side.Strength registered in kg. A ratio closer to zero signifies that pain occurs at the application of a small force signifying a more severe condition. A ratio approaching 1 signifies a milder complaint.

  9. Maximum Grip Strength Ratio

    Time frame: 6 weeks

    Maximum grip strength registered with hand held dynamometer. Mean of three measurements as ratio of affected to unaffected side. Strength registered in kg. A ratio closer to zero signifies that pain hampers the application of grip force to a larger degree signifying a more severe condition. A ratio approaching 1 signifies a milder complaint where grip strength is not hampered by pain.

  10. Maximum Grip Strength Ratio

    Time frame: 12 weeks

    Maximum grip strength registered with hand held dynamometer. Mean of three measurements as ratio of affected to unaffected side. Strength registered in kg. A ratio closer to zero signifies that pain hampers the application of grip force to a larger degree signifying a more severe condition. A ratio approaching 1 signifies a milder complaint where grip strength is not hampered by pain.

  11. Maximum Grip Strength Ratio

    Time frame: 26 weeks

    Maximum grip strength registered with hand held dynamometer. Mean of three measurements as ratio of affected to unaffected side. Strength registered in kg. A ratio closer to zero signifies that pain hampers the application of grip force to a larger degree signifying a more severe condition. A ratio approaching 1 signifies a milder complaint where grip strength is not hampered by pain.

  12. Maximum Grip Strength Ratio

    Time frame: 52 weeks

    Maximum grip strength registered with hand held dynamometer. Mean of three measurements as ratio of affected to unaffected side.Strength registered in kg. A ratio closer to zero signifies that pain hampers the application of grip force to a larger degree signifying a more severe condition. A ratio approaching 1 signifies a milder complaint where grip strength is not hampered by pain.

  13. Affected Function on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 6 weeks

    To what extent is the use of the elbow affected registered on 100 mm VAS-scale. 0 mm represents use not affected. 100 mm signifies maximum affected function. Higher scores mean a worse outcome.

  14. Affected Function on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 12 weeks

    To what extent is the use of the elbow affected registered on 100 mm VAS-scale. 0 mm represents use not affected. 100 mm signifies maximum affected function. Higher scores mean a worse outcome.

  15. Affected Function on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 26 weeks

    To what extent is the use of the elbow affected registered on 100 mm VAS-scale. 0 mm represents use not affected. 100 mm signifies maximum affected function. Higher scores mean a worse outcome.

  16. Affected Function on a 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 52 weeks

    To what extent is the use of the elbow affected registered on 100 mm VAS-scale. 0 mm represents use not affected. 100 mm signifies maximum affected function. Higher scores mean a worse outcome.

  17. Overall Complaint on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 6 weeks

    Overall complaint registered on VAS-scale as recorded by study doctors. 0 mm represents no overall complaint. 100 mm signifies maximum overall complaint. Higher scores mean a worse outcome.

  18. Overall Complaint on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 12 weeks

    Overall complaint registered on VAS-scale as recorded by study doctors. 0 mm represents no overall complaint. 100 mm signifies maximum overall complaint. Higher scores mean a worse outcome.

  19. Overall Complaint on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 26 weeks

    Overall complaint registered on VAS-scale as recorded by study doctors. 0 mm represents no overall complaint. 100 mm signifies maximum overall complaint. Higher scores mean a worse outcome.

  20. Overall Complaint on 100 mm VAS-scale as Recorded by the Study Doctors

    Time frame: 52 weeks

    Overall complaint registered on VAS-scale as recorded by study doctors. 0 mm represents no overall complaint. 100 mm signifies maximum overall complaint. Higher scores mean a worse outcome.

  21. Pain Free Function Index of Everyday Activities

    Time frame: 6 weeks

    Pain free function Index ( 0 - 8 ; 0: full function, 8 no function). Does the patient have pain on 8 every-day activities (dressing, eating, washing, household tasks, opening doors, carrying objects, with work, at sports). Recording a 0 on a complaint listed signifies full function, recording a 1 signifies no function. Thus the more activities with no function the higher score and the higher impairment.

  22. Pain Free Function Index of Everyday Activities

    Time frame: 12 weeks

    Pain free function Index ( 0 - 8 ; 0: full function, 8 no function). Does the patient have pain on 8 every-day activities (dressing, eating, washing, household tasks, opening doors, carrying objects, with work, at sports). Recording a 0 on a complaint listed signifies full function, recording a 1 signifies no function. Thus the more activities with no function the higher score and the higher impairment.

  23. Pain Free Function Index of Everyday Activities

    Time frame: 26 weeks

    Pain free function Index ( 0 - 8 ; 0: full function, 8 no function). Does the patient have pain on 8 every-day activities (dressing, eating, washing, household tasks, opening doors, carrying objects, with work, at sports). Recording a 0 on a complaint listed signifies full function, recording a 1 signifies no function. Thus the more activities with no function the higher score and the higher impairment.

  24. Pain Free Function Index of Everyday Activities

    Time frame: 52 weeks

    Pain free function Index ( 0 - 8 ; 0: full function, 8 no function). Does the patient have pain on 8 every-day activities (dressing, eating, washing, household tasks, opening doors, carrying objects, with work, at sports). Recording a 0 on a complaint listed signifies full function, recording a 1 signifies no function. Thus the more activities with no function the higher score and the higher impairment.

  25. No Pain on Three Point Likert Scale on Dorsiflexion of Wrist

    Time frame: 6 weeks

    Percentage of patients reporting "no pain" on dorsiflexion of wrist on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  26. No Pain on Three Point Likert Scale on Dorsiflexion of Wrist

    Time frame: 12 weeks

    Percentage of patients reporting "no pain" on dorsiflexion of wrist on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  27. No Pain on Three Point Likert Scale on Dorsiflexion of Wrist

    Time frame: 26 weeks

    Percentage of patients reporting "no pain" on dorsiflexion of wrist on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  28. No Pain on Three Point Likert Scale on Dorsiflexion of Wrist

    Time frame: 52 weeks

    Percentage of patients reporting "no pain" on dorsiflexion of wrist on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  29. No Pain on Three Point Likert Scale on Isometric Extension of Third Finger

    Time frame: 6 weeks

    Percentage of patients reporting "no pain" on isometric extension of third finger on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  30. No Pain on Three Point Likert Scale on Isometric Extension of Third Finger

    Time frame: 12 weeks

    Percentage of patients reporting "no pain" on isometric extension of third finger on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  31. No Pain on Three Point Likert Scale on Isometric Extension of Third Finger

    Time frame: 26 weeks

    Percentage of patients reporting "no pain" on isometric extension of third finger on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

  32. No Pain on Three Point Likert Scale on Isometric Extension of Third Finger

    Time frame: 52 weeks

    Percentage of patients reporting "no pain" on isometric extension of third finger on a three-point Likert scale on dorsiflexion of wrist. Scale: No pain - some pain - definite pain.

Sponsors and collaborators

Lead sponsor

University of Oslo

Other

Collaborators

  • Allmennmedisinsk forskningsfond, Norway

Registry information

Official study title

Physiotherapy Alone, in Combination With Corticosteroid Injection or Wait-and-see for Acute Lateral Epicondylitis in General Practice: a Randomised, Placebo-controlled Study With 12 Months Follow-up

Important dates

Study start
2009
Primary completion
2013
Study completion
2013
First posted
Jan 22, 2009
Registry last updated
Jan 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.